Arundic acid ((2R)-2-propyloctanoic acid, ONO-2506) is an astrocyte-modulating agent that functions as a neuroprotective agent by inhibiting the synthesis of S100B protein, a calcium-binding protein associated with neurodegenerative diseases and brain injury. It has been investigated in clinical trials for conditions like acute ischemic stroke, Alzheimer’s disease, and Parkinson’s disease, showing promise in experimental models but also raising questions about potential associations with depression. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Cereact, Proglia and Arocyte. Its PubChem CID is 208925.
Arundic acid
| CAS No | 185517-21-9 |
|---|---|
| Molecular Formula | C11H22O2 |
| Molecular Weight | 186.29 g/mol |
| Synonyms | (2R)-2-propyloctanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Arundic acid ((2R)-2-propyloctanoic acid, ONO-2506) is an astrocyte-modulating agent that functions as a neuroprotective agent by inhibiting the synthesis of S100B protein, a calcium-binding protein associated with neurodegenerative diseases and brain injury.
The listed CAS number is 185517-21-9.
The listed molecular formula is C11H22O2.
The listed molecular weight is 186.29 g/mol.
(2R)-2-propyloctanoic acid.
The source lists Cereact, Proglia and Arocyte.